US Patent Issued to SHANGHAI KING-CELL BIOTECHNOLOGY, BEIJING CELL-FUSION BIOTECHNOLOGY on Dec. 2 for "F-genotype mumps virus attenuated strain and construction method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,497, issued on Dec. 2, was assigned to SHANGHAI KING-CELL BIOTECHNOLOGY Co. LTD. (Shanghai) and BEIJING CELL-FUSION BIOTECHNOLOGY Co. LTD. (Beijing).

"F-genotype mumps virus attenuated strain and construction method therefor and application thereof" was invented by Dayong Tian (Shanghai), Yajing Zhang (Shanghai), Fengcai Zhu (Shanghai), Zhenfang Fu (Shanghai), Lixia Xie (Shanghai), Yuanbao Liu (Shanghai), Juncheng Ruan (Shanghai), Jinliang Wang (Shanghai) and Qi An (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an F-genotype mumps virus attenuated strain, a construction method therefor and an application thereof. The attenuated...